Background. In some older adults, higher blood pressure (BP) is associated with a lower risk of mortality. We hypothesized that higher BP would be associated with greater mortality in high-functioning elders and lower mortality in elders with lower functional status.
1
T HERE is substantial evidence that the association of blood pressure (BP) and mortality differs by age. Epidemiological evidence suggests a U-shaped relationship between BP and poor outcomes in older adults; both low and high levels of BP are associated with worse prognosis ( 1 -4 ) . In the oldest old, the relationship between higher BP levels and lower risk of mortality is even more pronounced. In addition, the effectiveness of BP lowering drugs also appears to be attenuated with age. A large recent meta-analysis of randomized controlled trials illustrated a decreased effect of BP lowering drugs on coronary heart disease and stroke events in older adults ( 5 ) . Another meta-analysis of hypertension treatment trials limited to adults aged 80 years and older suggested that the benefi t of antihypertensive therapy for stroke risk might be offset by an increase in the risk of death ( 6 ) . In contrast, a recent large randomized controlled trial in adults aged 80 years and older , the Hy pertension in the V ery E lderly T rial, demonstrated a protective effect of antihypertensive therapy on stroke, cardiovascular events, heart failure, and all-cause mortality, after two years of treatment ( 7 ) . Notably, the treatment target for systolic BP in this trial was higher (150 mmHg) than in most prior studies in younger people, and the study population included few poor-functioning elders ( 7 ) .
The reasons for these differences in the associations between BP and outcomes in older adults remain unclear. One proposed explanation is that in poor -functioning older adults whom may have decrements in cardiovascular function, elevated BP may be a compensatory adaptation, necessary to maintain perfusion of vital organs, such as the brain or heart ( 8 , 9 ) . In these poor -functioning elders, low BP may be an indicator of greater disease burden and a marker for worse prognosis. Because old age is a period of exceptional heterogeneity in health and functional status, it is possible that these differences may explain the apparent contradictory fi ndings regarding the relationship between BP and mortality in older adults ( 8 ) .
Even less is known about the relationship between BP , functional status, and outcomes in race/ethnic minorities, The Association of Blood Pressure and Mortality Differs by Self-reported Walking Speed in Older Latinos where the aging population is less well -studied. Latinos are the fastest growing ethnic group in the U nited S tates ( 10 ) and may be at higher risk for functional impairment due to risk factors such as diabetes, obesity, and the metabolic syndrome ( 11 ) . In this study, we examined whether functional status, estimated by self-reported walking speed, modifi ed the relationship between BP and mortality in Latino older adults. We hypothesized that higher systolic and diastolic BP will be associated with increased risk of mortality in elders , who reported faster walking speed ; whereas , it would be associated with lower mortality in elders with slower self-reported walking speed. This analysis was conducted with data from the Sacramento Area Latino Study on Aging (SALSA), a cohort of 1,789 Mexican ancestry adults aged 60 years and older at baseline. This cohort had a wide range of physical function, which allowed us to examine the relationship between BP and mortality across a functionally diverse group of elders.
M ethods

Study P opulation
SALSA is a longitudinal cohort study of 1,789 communitydwelling Mexican Americans residing in California ' s Sacramento Valley who were aged 60 -101 years at baseline in 1998 -1999. The participants were born in Mexico or another Latin American country (51%) or in the U nited States (49%). The study population and the recruitment of SALSA participants have been described in detail elsewhere ( 12 ). Participants were followed every 12 -15 months via home visits that included clinical, cognitive , and functional assessments into 2008 for incident dementia and are still being followed for mortality. A semiannual phone call was made to obtain updates on medications, health events, and sociodemographic risk factors. SALSA was approved by the Institutional Review Boards at the University of Michigan and the University of California at San Francisco and Davis.
All-Cause and Cardiovascular Mortality
Mortality was ascertained through May, 2010 , through online obituary surveillance, review of the Social Security death index and the National Death Index, review of vital statistics data fi les from California, and interviews with family members to track those participants who had moved. Death certifi cates were obtained for 84% ( n = 375) of those known to be deceased. Information on cause of death was coded according to the Tenth Revision of the International Statistical Classifi cation of Diseases and Related Health Problems. Cardiovascular disease mortality was defi ned as deaths for which anywhere on the death certifi cate mentioned Tenth Revision codes for ischemic heart diseases (codes I20 -125), heart failure (code 150) , and stroke (codes I63, 164). If a death certifi cate was not located, the death was classifi ed as all-cause mortality, with the cause unspecifi ed. If the person was not known to be dead, they were coded as alive and censored at the date of last contact.
Blood Pressure
Sitting systolic and diastolic BP was measured at each home visit by automatic sphygmomanometer. Participants were asked to sit without talking for 10 minutes after which BP was measured twice with an interval of 5 minutes between the two measures. The two measures were averaged for this analysis.
Self-reported Walking Speed
Self-reported walking speed was used as a measure of functional status; this measure of walking activity was used to categorize walking ability. Participants were asked about their usual walking pace outdoors and were given six possible responses. Participants ' walking speed was classifi ed as " slow " if they responded " easy/casual , " " never walks outdoors , " or " unable to walk " ; " medium " if they responded " normal/average " ; and " fast " if they responded " brisk pace " or " very brisk/striding." Prior literature has demonstrated that self-reported walking measures correlate well with performance-based measures ( 13 ) . This measure captures participants ' self-perceived functional status across a wide range of function. A recent study in this j ournal demonstrated that self-reported measures of physical capacity that include a broad range of function have greater reliability and validity compared with those that measure function over a more narrow range of function (eg, inability or ability) ( 14 ) .
Other V ariables
Age, sex, education, and insurance were assessed at baseline by self-report. Baseline body mass index was calculated as weight (in kilograms) divided by height (in meters) squared. Baseline depressive symptoms were measured with the Center for Epidemiologic Studies-Depression ( 15 ); the scale ranges from 0 to 60. Baseline cognitive function was assessed using the Modifi ed Mini Mental State exam ( 16 ) , a test of global cognition with a scale of 0 -100 that has been validated and adapted for use in Mexican Americans. Total, high-density lipoprotein, and low-density lipoprotein cholesterol were measured in baseline serum samples as well as triglycerides, fasting glucose, creatinine, C-reactive protein, interleukin-6, and tumor necrosis factor-alpha. History of arthritis (in hands, shoulders, hips, or knees), myocardial infarction, stroke, heart failure, cancer, fracture, and hospitalization were assessed by self-report at baseline. Hypertension and diabetes medication use was assessed by medicine cabinet inventory at each annual visit and updated at the semiannual phone call. Classes of hypertension or diabetes medication were coded using the Centers for Disease Control and Prevention Ambulatory Care Drug Database System ( http :// www2 . cdc . gov / drugs / index . asp ).
Statistical Analysis
We fi rst compared the mean values of baseline characteristics from Table 1 of participants across categories of selfreported walking speed, based on an analysis of variance test (or nonparametric equivalent) for continuous variables and a chi-squared test for categorical variables. We examined the adjusted association of systolic and diastolic BP with all-cause and cardiovascular mortality in Cox proportional hazards models with age as the index time. Blood pressure, self-reported walking speed , and all potential confounders were assessed at baseline. All-cause mortality was the primary outcome of interest , and systolic BP was the primary independent variable of interest. Sex was included as a potential confounder in all models ; other candidate confounders included those variables listed above under other variables. A covariate was included in the adjusted model if it met the three following criteria: (a ) associated with mortality at a signifi cance level of p < .20, ( b ) associated with systolic BP at a signifi cance level of p < .20, ( c ) its inclusion in a multivariable model changed the magnitude of the coeffi cient for systolic BP or the coeffi cient for the interaction between systolic BP and self-reported walking speed by more than 5%. Of all measures examined, only the Modifi ed Mini Mental State exam , serum creatinine, interleukin-6 , and diabetes medication use met all of these criteria. Multiplicative interaction terms between systolic and diastolic BP and self-reported walking speed were included in the multivariable models, and subsequently, models were stratifi ed on self-reported walking speed. We used the Schoenfeld residuals to test if the proportional hazards assumption was met. In addition, we fi t models with baseline and time-varying terms for systolic and diastolic BP . As sensitivity analyses, we included multiple comorbid conditions ( myocardial infarction , stroke, heart failure, cancer, fracture, hospitalization) and antihypertensive medication use to test if the inclusion of these factors would attenuate the estimates of interest. In order to determine if the interaction between BP and self-reported walking speed was explained by an interaction between BP and age, we also tested whether inclusion of this interaction term would alter the relationship between BP and mortality across categories of self-reported walking speed. Finally, because falling BP levels can be an indicator of the end-oflife, we conducted a third sensitivity analysis, in which we excluded deaths in the fi rst year of follow-up.
For an alternative analysis, we classifi ed systolic BP as a binary variable. In order to identify a cutpoint for systolic BP which could be used to group participants based on their risk of mortality, we conducted a regression tree analysis of failure time to all-cause mortality ( 17 ) . Regression tree analysis is a commonly used data-mining tool that can be used to identify cutpoints for one or more predictor variables (ie , systolic BP and self-reported walking speed) that best distinguish between populations based on an outcome of interest (ie , time to death). We included the same adjustment variables included in the Cox proportional hazards models. We classifi ed high systolic BP based on the cutpoint identifi ed in this analysis (>160 mmHg) and conducted a Cox proportional hazards model to estimate the association of high systolic BP and mortality across categories of selfreported walking speed. All analyses were conducted with Stata 10.0 (StataCorp, College Station, TX).
R esults
Of 1,789 total participants, 1,562 had measured BP and reported walking speed at baseline and were included in this analysis; 465 were classifi ed slow walkers, 816 were medium-speed walkers, and 281 were fast walkers. On average, self-reported slow walkers were older, more likely to be women , have completed fewer years of education, were less likely to have insurance , and had higher depression scores and lower cognitive function compared with faster walkers. Slow walkers had higher body mass index and glucose compared with fast walkers. In addition, creatinine, C-reactive protein, and interleukin-6 levels were higher in slow walkers. Slow walkers also had higher prevalence of a history of arthritis, cardiovascular events, cancer, hospitalization, use of diabetes , and antihypertensive medications. Mean BP levels varied modestly across slow, medium, and fast walkers: 140, 139, and 136 mmHg (systolic), p value = .02, and 77, 76, and 75 mmHg (diastolic), p value = .02, respectively ( Table 1 ) .
Blood P ressure and S elf-reported W alking S peed
There were 442 deaths from 1998 to 2009; 375 were confi rmed by death certifi cate, and 53% (198/375) of confi rmed deaths were reported as from cardiovascular causes. Persons who were identifi ed as slower walkers had a greater risk of mortality compared with faster walkers over the follow-up period ( Figure 1 ) . The relationship between systolic BP and mortality varied across self-reported walking speed ( p value for interaction = .004). There was no relationship between higher systolic BP and mortality in par- ticipants who reported slow or medium speed walking. In contrast, higher systolic BP was associated with a 30% elevated risk of all-cause mortality in the fast walkers ( p = .005 ; Table 2 ). We observed similar relationships between diastolic BP and all-cause mortality across participants with varying self-reported walking speed. The point estimates for higher BP were in the protective direction in the slower walkers, and harmful in the faster walkers, although the estimates were highly variable , and none reached statistical signifi cance. As a secondary outcome, we examined the relationship between BP and cardiovascular mortality and observed a similar pattern ( Table 3 ). However, the statistical power was limited in this subgroup , and none of the estimates reached statistical signifi cance.
The estimates for the associations of systolic BP and all-cause mortality did not change appreciably when we included history of myocardial infarction , stroke, heart failure, cancer, fracture, and hospitalization in the model; the hazard ratios ( HRs ) per 10 mmHg higher systolic BP were 0.96 ( p = .26), 1.01 ( p = .78), and 1.30 ( p = .004) for slow, medium, and fast walkers, respectively. The inclusion of antihypertensive medication as an adjustment variable also did not change the estimates; the HRs were 0.95 ( p = .13), 1.00 ( p = .90), and 1.29 ( p = .005) for slow, medium, and fast walkers, respectively. The addition of a BP and a ge interaction term had a minor impact on the estimates; the HRs were 0.95 ( p = .45), 1.09 ( p = .10), 1.39 ( p = .002). Finally, the estimates were robust against the exclusion of deaths in the fi rst year; the HRs were 0.95 ( p = .17), 1.00 ( p = .99), and 1.31 ( p = .005) for slow, medium, and fast walkers, respectively.
Based on the regression tree analysis of systolic BP and self-reported walking speed and time to death, a cutpoint of 160 mmHg best distinguished between survival time in the fast and slow walkers. Systolic BP more than 160 mmHg was associated with a lower HR of death in slow walkers, 0.72 (95% confi dence interval : 0.49, 1.05), compared with fast walkers, 1.52 (0.52, 4.58), p value for interaction = .05 ( Figure 2 ).
D iscussion
We observed that the association of BP and mortality differs between low -and high-functioning older Latino adults. In participants with fast self-reported walking speed, higher systolic BP was associated with an elevated risk of mortality. This association was not observed among slow walkers. Latino elders have an elevated risk of functional decline because of the high prevalence of risk factors , including diabetes and obesity ( 18 , 19 ) . The study of this population with diverse physical functioning may allow us to gain insight into the relationship between BP , mortality , and functional status. Our fi ndings suggest that the functional status of elderly persons is an important factor to consider when studying the association between BP and the risk of mortality. If confi rmed in other racial/ethnic populations, measures of functional status may help clinicians to identify older adults who may benefi t the most from treatment of high BP . Our fi nding that higher systolic BP is associated with increased risk of death among fast walkers but not slow or medium walkers may be of particular clinical importance due to the high prevalence of isolated systolic hypertension in elderly adults ( 20 ) .
One of the earliest studies to suggest an impact of age on the relation between BP and survival in the U nited S tates was the Rancho Bernardo Study ( 1 ) . In a study population of 2,270 predominantly white adults, investigators reported a paradoxical association of higher diastolic BP and lower mortality ( p = .04 for trend) in men older than 75 years of age . They did not observe a similar relation in women or younger men, and the relation between systolic BP and mortality was inconclusive. Satish and colleagues ( 4 ) investigated the relationship between BP and 6-year mortality in the Established Populations for Epidemiological Studies of the Elderly, a cohort study of 12,802 community-dwelling elderly adults aged 65 years and older . The authors found a strong relationship between higher BP and lower mortality in adults aged 85 years and older ; the lowest risk of mortality was at 182 ± 22 mmHg systolic BP . In adults age d 65 -84 years, there was a U-shaped relation between systolic BP and mortality; the systolic BP associated with the lowest risk of mortality was 134 ± 3.3 mmHg; mortality risk was elevated at higher and lower BP levels. In older adults, elevated BP has been suggested as a compensatory mechanism to offset reductions in function in the cardiovascular system and a loss of elasticity in vasculature ( 8 , 9 ) . Higher BP may be necessary in frail elders to maintain perfusion of the vital organs, such as the brain and heart.
Whereas these prior studies have examined chronologic age as a potential modifi er of the relation between BP and mortality, functional status may be a better measure of physiologic aging. Walking speed is strongly associated with mortality, and slower walking speed may identify those individuals who have low reserves in any of a number of organ systems including the cardiovascular, respiratory, musculoskeletal, and nervous systems ( 21 ) . Selfreported walking speed is a subjective measure and may also be infl uenced by an individual ' s mood, motivation, and self-perception. In addition, the measure of selfperceived walking speed also likely partially captures a participant ' s physical activity. Prior research has demonstrated that self-reported measures of health and functional status are strongly associated with mortality and other outcomes ( 22 -25 ) .
Some have suggested that differences in the estimate of the association of BP and survival in older adults in observational studies are due to the conditions associated with lower BP , such as cancer, myocardial infarction , and heart failure; however, in the present study, adjustment for these factors did not infl uence our estimates. In addition, the differential relationship of BP and mortality in high -and lowfunctioning elders was present even after the exclusion of persons dying in the fi rst year of follow-up. Both systolic and diastolic BP were slightly higher in the slow walkers compared with the fast walkers, so the paradoxical relation of higher BP and lower mortality in slow walkers is not a result of abnormally low BP levels in these individuals. The SALSA cohort provided an opportunity to examine a relatively homogenous study population, with a wide range of functional status. The ethnic homogeneity of the study population is an advantage of the study because it reduces the potential for confounding by this factor. However, our study also has limitations , which should be considered. The primary limitation was the limited precision of the estimates ; the identifi cation of statistically signifi cant interaction terms typically require larger sample sizes than comparable main effects and may be subject to a higher likelihood of T ype II error. Therefore , we used other criteria to interpret the relevance of our fi ndings, namely the consistency of our results across BP measures, all-cause and cardiovascular disease mortality, and sensitivity analyses. However, we interpret the nonstatistically signifi cant fi ndings with caution because of the increase in risk of a T ype I error . An additional limitation was that many of the health status variables were determined by self-report, and there may be measurement error or misclassifi cation of these variables. Furthermore, death certifi cate data may be inaccurate in older adults with multiple comorbid conditions, so our ability to identify cause-specifi c mortality was limited.
Self-perceptions of walking speed may vary across populations and over time. We chose to use baseline measures of BP as our primary predictor of interest in order to compare our fi ndings with those studies that have examined the interaction between BP and age. The current research will inform future work that aims to better unravel the complex relationship between BP , functional status, and mortality over time. Finally, because this study was only conducted in Latino adults, the fi ndings should be confi rmed in a more ethnically diverse study population.
In conclusion, across levels of self-reported walking speed, we identifi ed a differential association of BP and mortality in this cohort of older Latino adults. If confi rmed in other studies, these fi ndings may help explain the paradoxical association between higher BP and lower mortality in some older populations. This could have important implications regarding the treatment of hypertension ; assessment of functional status may help to identify patients who may benefi t the most from treatment of high BP . with all-cause mortality differs in older Latino adults with self-reported slow, medium, and fast walking speed. This association was assessed in a Cox proportional hazards model, adjusted for age, gender, cognitive function, creatinine, interleukin-6, and diabetes medication use. The overall p value for interaction between high systolic blood pressure and walking speed was .10 .
